These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18508880)

  • 21. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
    Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The distribution pattern of intravenous [(14)C] artesunate in rat tissues by quantitative whole-body autoradiography and tissue dissection techniques.
    Li Q; Xie L; Zhang J; Weina PJ
    J Pharm Biomed Anal; 2008 Nov; 48(3):876-84. PubMed ID: 18762400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolites in safety testing (MIST): considerations of mechanisms of toxicity with dose, abundance, and duration of treatment.
    Smith DA; Obach RS
    Chem Res Toxicol; 2009 Feb; 22(2):267-79. PubMed ID: 19166333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative assessment of reactive metabolite formation using 35S-labeled glutathione.
    Takakusa H; Masumoto H; Makino C; Okazaki O; Sudo K
    Drug Metab Pharmacokinet; 2009; 24(1):100-7. PubMed ID: 19252339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel bioactivation pathway for 2-[2-(2,6-dichlorophenyl)aminophenyl]ethanoic acid (diclofenac) initiated by cytochrome P450-mediated oxidative decarboxylation.
    Grillo MP; Ma J; Teffera Y; Waldon DJ
    Drug Metab Dispos; 2008 Sep; 36(9):1740-4. PubMed ID: 18541695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A toxicity risk index, an index for warning idiosyncratic drug toxicity.
    Morimoto M; Samizo K; Ohta S; Mizuma T
    J Pharm Sci; 2013 Sep; 102(9):3447-50. PubMed ID: 23666879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraoperative therapy with liposomal drug delivery: retention and distribution in human head and neck squamous cell carcinoma xenograft model.
    Wang SX; Bao A; Phillips WT; Goins B; Herrera SJ; Santoyo C; Miller FR; Otto RA
    Int J Pharm; 2009 May; 373(1-2):156-64. PubMed ID: 19429301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A method for rapidly predicting drug tissue distribution using surfactant vesicle electrokinetic chromatography.
    Jiang Z; Reilly J; Everatt B
    Electrophoresis; 2008 Sep; 29(17):3674-84. PubMed ID: 18803182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of infliximab on hepatic cytochrome P450 and pharmacokinetics of verapamil in rats with pre-adjuvant arthritis: a drug-disease and drug-drug interaction.
    Ling S; Jamali F
    Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):24-9. PubMed ID: 19371259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical pharmacokinetics and in vitro activity of ON 01910.Na, a novel anti-cancer agent.
    Chun AW; Cosenza SC; Taft DR; Maniar M
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):177-86. PubMed ID: 19466411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue slices for the evaluation of metabolism-based toxicity with the example of diclofenac.
    Vickers AE
    Chem Biol Interact; 2009 Apr; 179(1):9-16. PubMed ID: 19000659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biodistribution of radiolabeled ethanol in rodents.
    Gifford AN; Espaillat MP; Gatley SJ
    Drug Metab Dispos; 2008 Sep; 36(9):1853-8. PubMed ID: 18566042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and animal models of drug-induced blood dyscrasias.
    Ip J; Uetrecht JP
    Environ Toxicol Pharmacol; 2006 Feb; 21(2):135-40. PubMed ID: 21783650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Covalent binding of drugs to tissue macromolecules as a biochemical mechanism of drug toxicities with special emphasis on chloramphenicol and thiamphenicol.
    Krishna G
    Postgrad Med J; 1974 Oct; 50 Suppl 5():73-7. PubMed ID: 4470823
    [No Abstract]   [Full Text] [Related]  

  • 35. Trimethoprim: novel reactive intermediates and bioactivation pathways by cytochrome p450s.
    Damsten MC; de Vlieger JS; Niessen WM; Irth H; Vermeulen NP; Commandeur JN
    Chem Res Toxicol; 2008 Nov; 21(11):2181-7. PubMed ID: 18816075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Handling reactive metabolite positives in drug discovery: What has retrospective structure-toxicity analyses taught us?
    Kalgutkar AS
    Chem Biol Interact; 2011 Jun; 192(1-2):46-55. PubMed ID: 20833160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A targeted proteomics approach to the identification of peptides modified by reactive metabolites.
    Tzouros M; Pähler A
    Chem Res Toxicol; 2009 May; 22(5):853-62. PubMed ID: 19317514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytochrome P450 oxidation of the thiophene-containing anticancer drug 3-[(quinolin-4-ylmethyl)-amino]-thiophene-2-carboxylic acid (4-trifluoromethoxy-phenyl)-amide to an electrophilic intermediate.
    Medower C; Wen L; Johnson WW
    Chem Res Toxicol; 2008 Aug; 21(8):1570-7. PubMed ID: 18672911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution, metabolism and excretion of a synthetic androgen 7alpha-methyl-19-nortestosterone, a potential male-contraceptive.
    Prasad PV; Arumugam R; Willman M; Ge RS; Sitruk-Ware R; Kumar N
    Steroids; 2009 Jan; 74(1):121-31. PubMed ID: 18992267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
    Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
    Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.